Drugs / Trizivir
Regulatory milestones approvals, filings & regulatory actions · 2 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Approved | EU (EMA) | Trizivir | — | 2000-12-27 | europa.eu ↗ |
| Approved | US (FDA) | TRIZIVIR | — | 2000-11-14 | fda.gov ↗ |
Trials 4
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 32 trials | ||||||
| Phase 3 | NCT00405925 | Mar 2003 → Aug 2009 | HIV infectious disease | Rijnstate Hospital | Completed | No outcome recorded |
| Phase 3 | NCT00043888 | Jan 2002 → May 2003 | HIV infectious disease | GlaxoSmithKline | Completed | No outcome recorded |
| Phase 42 trials | ||||||
| Phase 4 | NCT00449436 | Jan 2005 → Dec 2007 | HIV infectious disease | GlaxoSmithKline | Completed | No outcome recorded |
| Phase 4 | NCT00127972 | Feb 2004 → Apr 2007 | HIV infectious disease | International Antiviral Therapy Evaluation Center | Completed | No outcome recorded |
| Comparator or background therapy2 trials | ||||||
| Phase 4 | NCT00960622 Comparator | Aug 2006 → Jul 2009 | HIV infectious disease | St. Luke's-Roosevelt Hospital Center | Completed | Missed primary |
| Phase 4 | NCT00979706 Comparator | Mar 2005 → Nov 2014 | HIV infectious disease | Juan A. Arnaiz | Completed | No outcome recorded |
Press releases naming this drug 1 release
| Date | Issuer | Release |
|---|---|---|
| 2013-12-18 | GlaxoSmithKline | Update on Patent Ruling on ViiV Healthcare's EPZICOM® and TRIZIVIR® gsk.com ↗ |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 6 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Trizivir | “Patients assigned to this arm will receive Trizivir and kaletra.” NCT00979706 ↗ |